Thymosin Beta-4 vs Wolverine — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Thymosin Beta-4 (TB-4) is the full-length 43-amino acid actin-sequestering peptide from which the commonly used research fragment TB-500 (residues 17-23, LKKTETQ) is derived. TB-4 is the most abundant thymosin-family protein in virtually all mammalian cells, where it maintains th...
Calculate Thymosin Beta-4 dose →Wolverine is a research peptide blend combining BPC-157 (5 mg) and TB-500 (5 mg) in a single vial. BPC-157 drives localized tissue repair and gut protection via angiogenesis; TB-500 promotes systemic cell migration and actin remodeling. Together they target overlapping healing pa...
Calculate Wolverine dose →| Parameter | Thymosin Beta-4 | Wolverine |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Extensively Studied | Research Blend |
| Half-Life | ~30-60 min (plasma) | BPC-157: 4-6 h; TB-500: ~5 days |
| Typical Dose | 1.5-2.5 mg, 2-3x/week | 500-1,000 µg |
| Frequency | 2-3 times per week | 2-3x per week |
| Route | Subcutaneous, IV, Topical, Intranasal | Subcutaneous |
| FDA Status | Phase II | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.